格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助,这一举措是为了研究口服免疫疗法的给药方案,以供美国军队使用。Immuron是一家处于临床阶段的医疗公司,专注于一种新型特异性... 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-018441 Act: 34 Size: 266 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-018328 Act: 34 Size: 474 KB 网页链接
$Immuron(IMRN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-20-018305 Act: 33 Size: 366 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-018220 Act: 34 Size: 66 KB 网页链接
$Immuron(IMRN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001535610-20-000105 Act: 34 Size: 13 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-018030 Act: 34 Size: 77 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-017859 Act: 34 Size: 70 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-016649 Act: 34 Size: 486 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-015528 Act: 34 Size: 389 KB 网页链接
$Immuron(IMRN)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-015368 Act: 34 Size: 4 MB 网页链接